DawaiSaathi

DawaiSathi ("Medicine Companion") is an AI-powered medication management platform accessible via Telegram and mobile web that helps Indians understand prescriptions, adhere to medication schedules, and find cost-saving generic alternatives — all in their local language.

Description

DawaiSathi is an ambitious AI-driven healthcare platform built by Team HealthTech Innovators, designed specifically to address the massive gap in medication literacy and adherence across India's 1.3 billion population. At its core, the platform leverages Claude AI to read and interpret handwritten or photographed prescriptions, breaking down complex medical information into simple, easy-to-understand explanations delivered in Hindi and other regional Indian languages, with voice output to support low-literacy users. Deployed primarily through Telegram — which already has over 100 million Indian users and requires zero installation — DawaiSathi provides a frictionless entry point for patients of all backgrounds, with a planned migration path to WhatsApp post-launch. The platform goes far beyond just explaining prescriptions: it features intelligent, context-aware medication reminders that account for food timing, a real-time drug interaction and allergy safety checker, a cost optimizer that identifies generic alternatives saving families up to 80–90% on medicine costs (approximately ₹530/month per family), and a health journal with AI-powered symptom tracking and pre-doctor visit summaries. A Caregiver Connect feature allows family members to receive missed-dose alerts and monitor elderly or dependent patients remotely, while seamless integration with India's ABHA/Ayushman Bharat digital health and insurance systems enables unified health records and claim support. Built on a robust AWS cloud architecture using serverless Lambda functions, RDS PostgreSQL, S3, and powered by the Claude API for AI reasoning and Google TTS for voice, the platform supports 8 Indian languages and is designed to auto-scale from 100 to 1 million users with no code changes. A pilot study with 50 families over two weeks showed medication adherence jumping from 38% to 87%, and hospital visits dropping by 83%, demonstrating the platform's potential to transform public health outcomes at a national scale.

Issues & Pull Requests Thread
No issues or pull requests added.